The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Roadmap for implementation of quality by design (QbD) for biotechnology products
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Quality by design for biopharmaceuticals
Rathore, A. S., & Winkle, H. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-26 · Cited by 830
Self-citationMire-Sluis, A. R., Barrett, Y. C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.002 · Cited by 624
Section XXIV. Partition Chromatographs
(2009) · Biotechnology · doi:10.1201/9781420084498-31 · Cited by 590
Quality by Design in Biopharmaceuticals
Yang, H. (2016) · doi:10.1201/9781315371726-7 · Cited by 543
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
Butler, M. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1980-8 · Cited by 469
The FDA Critical Path Initiative and Its Influence on New Drug Development
Woodcock, J., & Woosley, R. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.090506.155819 · Cited by 434
Applications of process analytical technology to crystallization processes
Yu, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.012 · Cited by 323
Shankar, G., Pendley, C., & Stein, K. E. (2007) · Nature Biotechnology · doi:10.1038/nbt1303 · Cited by 260
Gupta, S., Indelicato, S. R., Jethwa, V., Kawabata, T., Kelley, M., Mire-Sluis, A. R., Richards, S. M., Rup, B., Shores, E., Swanson, S. J., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.004 · Cited by 241
Current and future issues in the manufacturing and development of monoclonal antibodies
Kozlowski, S., & Swann, P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.05.002 · Cited by 170
Gnoth, S., Jenzsch, M., Simutis, R., & Lübbert, A. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.03.020 · Cited by 127
Rathore, A. S., Yu, M., Yeboah, S., & Sharma, A. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21759 · Cited by 126
Self-citationKirdar, A., Green, K. D., & Rathore, A. (2008) · Biotechnology progress (Print) · doi:10.1021/bp0704384 · Cited by 102
Self-citationDefining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation
Harms, J., Wang, X., Kim, T., Yang, X., & Rathore, A. S. (2008) · Biotechnology Progress · doi:10.1021/bp070338y · Cited by 101
Self-citationKirdar, A. O., Conner, J. S., Baclaski, J., & Rathore, A. S. (2007) · Biotechnology Progress · doi:10.1021/bp060377u · Cited by 99
Self-citationSenger, R. S., & Karim, M. N. (2003) · Biotechnology Progress · doi:10.1021/bp025715f · Cited by 82
Rathore, A. S., Wood, R., Sharma, A., et al. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21982 · Cited by 46
Self-citationProcess Validation in Manufacturing of Biopharmaceuticals
Rathore, A. S., Rathore, A. S., & Sofer, G. K. (2012) · CRC Press eBooks · doi:10.1201/b12013 · Cited by 41
Self-citationConsiderations for Biotechnology Product Quality by Design
Kozlowski, S., & Swann, P. G. (2008) · Wiley eBooks · doi:10.1002/9780470466315.ch2 · Cited by 34
Case Study on Definition of Process Design Space for a Microbial Fermentation Step
van Hoek, P., Harms, J., Wang, X., & Rathore, A. S. (2008) · Wiley eBooks · doi:10.1002/9780470466315.ch5 · Cited by 23
Self-citationUsing a Risk Assessment Process to Determine Criticality of Product Quality Attributes
Schenerman, M. A., Axley, M. J., Oliver, C. N., Ram, K., & Wasserman, G. F. (2008) · Wiley eBooks · doi:10.1002/9780470466315.ch4 · Cited by 14
Cited by
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Nanoparticles in Daily Life: Applications, Toxicity and Regulations
Gupta, R., & Xie, H. (2018) · Journal of Environmental Pathology, Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2018026009 · Cited by 553
Aggregates in monoclonal antibody manufacturing processes
Vázquez‐Rey, M., & Lang, D. A. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23155 · Cited by 479
Polymer therapeutics-prospects for 21st century: The end of the beginning
Duncan, R., & Vicent, M. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.012 · Cited by 412
Process analytical technology (PAT) for biopharmaceutical products
Rathore, A. S., Bhambure, R., & Ghare, V. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3781-x · Cited by 368
Self-citation
Metadata
- Authors
- Rathore, A. S.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 27
- Issue
- 9
- Pages
- 546-553
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W1989801492
- Cited by
- 411
- References
- 22
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.